Navigation Links
NUS study shows effectiveness of common anti-malarial drug in controlling asthma
Date:8/1/2014

Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore (NUS).

The team, led by Associate Professor Fred Wong from the Department of Pharmacology at the NUS Yong Loo Lin School of Medicine, together with Dr Eugene Ho Wanxing, a recent PhD graduate from the Saw Swee Hock School of Public Health at NUS, discovered that artesunate, a common herbal-based anti-malarial drug, can be used to control asthma, with better treatment outcomes than other drugs currently available.

In their latest work, the team revealed for the first time that artesunate is able to suppress airway inflammation and produce an array of anti-inflammatory effects similar to those by dexamethasone, the most potent steroid currently available, and with less side effects. This breakthrough discovery was first published in the journal Metabolomics on 16 July 2014.

Earlier this year, the NUS team was invited by renowned journal Pharmacology and Therapeutics to pen a comprehensive review of the pharmacological effects of artesunate, and the review article was published in the journal in April 2014.

The quest for better asthma therapeutics

Asthma is an incurable lung disease that inflames and narrows the airways, causing recurring periods of wheezing, chest tightness, coughing and shortness of breath. It is a chronic condition that affects people of all ages, but it most often starts during childhood.

To address the global unmet demand for better therapeutics to control allergic asthma, Dr Ho explored the therapeutic values of artesunate, which is herbal-based, as an alternative drug candidate. This study was part of Dr Ho's final-year project when he was pursuing a Bachelor of Science in Life Sciences at NUS. His initial findings demonstrated that artesunate possessed promising anti-inflammatory potent
'/>"/>

Contact: Carolyn Fong
carolyn@nus.edu.sg
65-651-65399
National University of Singapore
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Study of bigeye tuna in Northwest Atlantic uses new tracking methods
2. UF study advances DNA revolution, tells butterflies evolutionary history
3. Study of twins discovers gene mutation linked to short sleep duration
4. Study finds benefits to burning Flint Hills prairie in fall and winter
5. UT Dallas study reveals effect of loud noises on brain
6. New international tree nut council study looks at nuts, diabetes and metabolic syndrome
7. Study: Marine pest provides advances in maritime anti-fouling and biomedicine
8. Healthy lifestyle may buffer against stress-related cell aging, study says
9. Study suggests disruptive effects of anesthesia on brain cell connections are temporary
10. Study finds Europes habitat and wildlife is vulnerable to climate change
11. Dinosaurs fell victim to perfect storm of events, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NUS study shows effectiveness of common anti-malarial drug in controlling asthma
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 ... systems, announced today it will unveil its "Guardian S" ... at the National Tactical Officers Association Conference on August ... Guardian S is the first-ever commercially available energetically autonomous ... research and in-field trials and is protected by more ...
(Date:8/20/2015)... , Aug. 20, 2015   Sensory, ... on improving the user experience and security of ... technologies, today announced that its TrulySecure™ ... authentication software to be FIDO Certified™. ... for compliance with the FIDO UAF (Universal Authentication ...
(Date:8/18/2015)... DUBLIN , Aug. 17, 2015 ... the addition of the "Global Biometric Authentication ... Application - Estimation & Forecast, 2015-2020" report ... biometric authentication and identification systems market is expected ... from 2015 to 2020 and generate over $25 ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... voices is second nature to humans. Certain primates also ... social groups are also able to do so, however, ... for meerkats. They coordinate their activities with calls, such ... for instance, and thus stick together as a group. ...
... publishing workflow of eight journals published by Pensoft has ... data archiving for data files associated with articles in these journals. ... the online editorial management platform, Pensoft Journal System (PJS). The ... MycoKeys , BioRisk , NeoBiota , Nature Conservation ...
... Studies have estimated that converting manure from the 95 million ... equal to 8 billion gallons of gasoline, or 1% of ... and more farmers and communities are interested in generating renewable ... information on the economic feasibility and sustainability of such programs. ...
Cached Biology News:Meerkats recognize each other from their calls 2Data publishing in Pensoft journals integrated with the Dryad Data Repository 2Does converting cow manure to electricity pay off? 2
(Date:8/31/2015)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC ... announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd. ... an Investigational New Drug (IND) application for the topical ... completed a study in a rat model of dry ... efficacy and a more rapid onset of action than ...
(Date:8/31/2015)... , Aug. 31, 2015 LabStyle Innovations ... Management Solution, today announced it recently closed a ... will be used to support the global rollout ... a mobile, cloud-based, diabetes management solution that includes ... pocket-sized, blood glucose monitoring device, and for working ...
(Date:8/31/2015)... ... August 31, 2015 , ... Proove Biosciences, Inc. is a ... Annual High Tech Awards. , Now in its 22nd year, this premier awards ... innovation here, across the nation and around the world. The OC Tech Alliance will ...
(Date:8/28/2015)... PA (PRWEB) , ... August 28, 2015 , ... ... Chairman, Chuck Gardner, has organized and will present a session on chemical spectroscopic ... 2. This conference and exposition is Asia’s largest analytical and scientific instruments show ...
Breaking Biology Technology:Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 2U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 3
... Venture: QPT, EDMONTON, June 2 /PRNewswire-FirstCall/ - ... today announced that its 12-patient,Phase I clinical study ... for,the Photodynamic Therapy of Actinic Keratosis" has met ... delighted to have received, for the first time, ...
... (TSX: GEN), a,company focused on developing blood-based biomarker ... health management, today announced,management changes to support the ... May 31, 2008, Dr. K. Wayne Marshall has ... duties as Chief Clinical Scientist for GeneNews. Dr.,Marshall ...
... Tests identify genetic mutations that can affect patient response to ... ... Roche and DxS Ltd. have,signed an exclusive distribution agreement for the ... tests are,intended, when considered with other clinically relevant factors, to aid,doctors ...
Cached Biology Technology:Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis 2Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis 3GeneNews announces management changes to support commercialization of ColonSentry(TM) 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 3
... Nepheloskan Ascent is the first ... in microplates. Nepheloskan measures light ... technique for particle quantification. This ... testing in drug discovery, immunoprecipitation, ...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
... are used to assess the effect of drugs ... mice and rats using one unit in a ... animals are placed on textured drums to avoid ... sensing platforms below, its test results are recorded. ...
Biology Products: